These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 35219876)

  • 1. Viroporins: Structure, function, and their role in the life cycle of SARS-CoV-2.
    Breitinger U; Farag NS; Sticht H; Breitinger HG
    Int J Biochem Cell Biol; 2022 Apr; 145():106185. PubMed ID: 35219876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Severe Acute Respiratory Syndrome Coronavirus Viroporins E, 3a, and 8a in Replication and Pathogenesis.
    Castaño-Rodriguez C; Honrubia JM; Gutiérrez-Álvarez J; DeDiego ML; Nieto-Torres JL; Jimenez-Guardeño JM; Regla-Nava JA; Fernandez-Delgado R; Verdia-Báguena C; Queralt-Martín M; Kochan G; Perlman S; Aguilella VM; Sola I; Enjuanes L
    mBio; 2018 May; 9(3):. PubMed ID: 29789363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Channel activity of SARS-CoV-2 viroporin ORF3a inhibited by adamantanes and phenolic plant metabolites.
    Fam MS; Sedky CA; Turky NO; Breitinger HG; Breitinger U
    Sci Rep; 2023 Apr; 13(1):5328. PubMed ID: 37005439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 Viroporin E Induces Ca
    López-Vázquez S; Villalobos C; Núñez L
    Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hijacking of Cellular Functions by Severe Acute Respiratory Syndrome Coronavirus-2. Permeabilization and Polarization of the Host Lipid Membrane by Viroporins.
    Bignon E; Marazzi M; Monari A
    J Phys Chem Lett; 2022 Jun; 13(21):4642-4649. PubMed ID: 35593652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The antiviral targeting potential of viroporins].
    Sund JD; Bollerup S; Glamann JB; Vinten CA; Jensen LR; Toft-Bethelsen TL; Bentzen BH; Kledal TN; Weis N; Rosenkilde M
    Ugeskr Laeger; 2022 Jun; 184(24):. PubMed ID: 35703076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The envelope proteins from SARS-CoV-2 and SARS-CoV potently reduce the infectivity of human immunodeficiency virus type 1 (HIV-1).
    Henke W; Waisner H; Arachchige SP; Kalamvoki M; Stephens E
    Retrovirology; 2022 Nov; 19(1):25. PubMed ID: 36403071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patch-clamp studies and cell viability assays suggest a distinct site for viroporin inhibitors on the E protein of SARS-CoV-2.
    Breitinger U; Sedky CA; Sticht H; Breitinger HG
    Virol J; 2023 Jul; 20(1):142. PubMed ID: 37422646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unravelling the Immunomodulatory Effects of Viral Ion Channels, towards the Treatment of Disease.
    Gargan S; Stevenson NJ
    Viruses; 2021 Oct; 13(11):. PubMed ID: 34834972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In silico investigation of the viroporin E as a vaccine target against SARS-CoV-2.
    Rouka E; Gourgoulianis KI; Zarogiannis SG
    Am J Physiol Lung Cell Mol Physiol; 2021 Jun; 320(6):L1057-L1063. PubMed ID: 33822639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting host calcium channels and viroporins: a promising strategy for SARS-CoV-2 therapy.
    Fani M; Moossavi M; Bakhshi H; Jahrodi AN; Khazdair MR; Zardast AH; Ghafari S
    Future Virol; 2023 Aug; ():. PubMed ID: 37700758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In silico identification of Tretinoin as a SARS-CoV-2 envelope (E) protein ion channel inhibitor.
    Dey D; Borkotoky S; Banerjee M
    Comput Biol Med; 2020 Dec; 127():104063. PubMed ID: 33126128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocardial Damage by SARS-CoV-2: Emerging Mechanisms and Therapies.
    Ho HT; Peischard S; Strutz-Seebohm N; Klingel K; Seebohm G
    Viruses; 2021 Sep; 13(9):. PubMed ID: 34578462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reply to: How Many SARS-CoV-2 "Viroporins" Are Really Ion Channels?
    Toft-Bertelsen TL; Jeppesen MG; Landbrug A; Mujezinovic A; Bentzen BH; Kledal TN; Rosenkilde MM
    Commun Biol; 2022 Aug; 5(1):860. PubMed ID: 36008476
    [No Abstract]   [Full Text] [Related]  

  • 15. How many SARS-CoV-2 "viroporins" are really ion channels?
    Harrison NL; Abbott GW; Gentzsch M; Aleksandrov A; Moroni A; Thiel G; Grant S; Nichols CG; Lester HA; Hartel A; Shepard K; Garcia DC; Yazawa M
    Commun Biol; 2022 Aug; 5(1):859. PubMed ID: 36008538
    [No Abstract]   [Full Text] [Related]  

  • 16. COVID-19, Cation Dysmetabolism, Sialic Acid, CD147, ACE2, Viroporins, Hepcidin and Ferroptosis: A Possible Unifying Hypothesis.
    Cavezzi A; Menicagli R; Troiani E; Corrao S
    F1000Res; 2022; 11():102. PubMed ID: 35340277
    [No Abstract]   [Full Text] [Related]  

  • 17. Viroporins Manipulate Cellular Powerhouses and Modulate Innate Immunity.
    Cedillo-Barrón L; García-Cordero J; Visoso-Carvajal G; León-Juárez M
    Viruses; 2024 Feb; 16(3):. PubMed ID: 38543711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of SARS CoV Envelope Protein by Flavonoids and Classical Viroporin Inhibitors.
    Breitinger U; Ali NKM; Sticht H; Breitinger HG
    Front Microbiol; 2021; 12():692423. PubMed ID: 34305855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functions of Viroporins in the Viral Life Cycle and Their Regulation of Host Cell Responses.
    Xia X; Cheng A; Wang M; Ou X; Sun D; Mao S; Huang J; Yang Q; Wu Y; Chen S; Zhang S; Zhu D; Jia R; Liu M; Zhao XX; Gao Q; Tian B
    Front Immunol; 2022; 13():890549. PubMed ID: 35720341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe Acute Respiratory Syndrome Coronavirus Viroporin 3a Activates the NLRP3 Inflammasome.
    Chen IY; Moriyama M; Chang MF; Ichinohe T
    Front Microbiol; 2019; 10():50. PubMed ID: 30761102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.